mofezolac has been researched along with 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fortuna, CG; Panella, A; Perrone, MG; Scilimati, A; Vitale, P | 1 |
| Armen, RS; Cingolani, G; Di Mauro, G; Ferorelli, S; Fortuna, CG; Panella, A; Perrone, MG; Scilimati, A; Smith, WL; Vitale, P | 1 |
2 other study(ies) available for mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole
| Article | Year |
|---|---|
General role of the amino and methylsulfamoyl groups in selective cyclooxygenase(COX)-1 inhibition by 1,4-diaryl-1,2,3-triazoles and validation of a predictive pharmacometric PLS model.
Topics: Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Least-Squares Analysis; Molecular Structure; Reproducibility of Results; Structure-Activity Relationship; Triazoles | 2015 |
Structural basis for selective inhibition of Cyclooxygenase-1 (COX-1) by diarylisoxazoles mofezolac and 3-(5-chlorofuran-2-yl)-5-methyl-4-phenylisoxazole (P6).
Topics: Cyclooxygenase 1; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Isoxazoles; Molecular Structure; Structure-Activity Relationship | 2017 |